313 related articles for article (PubMed ID: 35248559)
1. Topical ocular drug delivery systems: Innovations for an unmet need.
Yang Y; Lockwood A
Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
3. Advances in ophthalmic drug delivery.
Morrison PW; Khutoryanskiy VV
Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
[TBL] [Abstract][Full Text] [Related]
4. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic drug dosage forms: characterisation and research methods.
Baranowski P; Karolewicz B; Gajda M; Pluta J
ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
[TBL] [Abstract][Full Text] [Related]
6. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for drug delivery to the anterior segment of the eye.
Janagam DR; Wu L; Lowe TL
Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies.
Mofidfar M; Abdi B; Ahadian S; Mostafavi E; Desai TA; Abbasi F; Sun Y; Manche EE; Ta CN; Flowers CW
Int J Pharm; 2021 Sep; 607():120924. PubMed ID: 34324989
[TBL] [Abstract][Full Text] [Related]
10. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.
Wang C; Pang Y
Adv Drug Deliv Rev; 2023 Mar; 194():114721. PubMed ID: 36773886
[TBL] [Abstract][Full Text] [Related]
11. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
12. Strategies to prolong the residence time of drug delivery systems on ocular surface.
Grassiri B; Zambito Y; Bernkop-Schnürch A
Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
[TBL] [Abstract][Full Text] [Related]
13. Principles of pharmacology in the eye.
Awwad S; Mohamed Ahmed AHA; Sharma G; Heng JS; Khaw PT; Brocchini S; Lockwood A
Br J Pharmacol; 2017 Dec; 174(23):4205-4223. PubMed ID: 28865239
[TBL] [Abstract][Full Text] [Related]
14. Contact lenses: promising devices for ocular drug delivery.
Guzman-Aranguez A; Colligris B; Pintor J
J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
[TBL] [Abstract][Full Text] [Related]
15. Gelling hypotonic polymer solution for extended topical drug delivery to the eye.
Kim YC; Shin MD; Hackett SF; Hsueh HT; Lima E Silva R; Date A; Han H; Kim BJ; Xiao A; Kim Y; Ogunnaike L; Anders NM; Hemingway A; He P; Jun AS; McDonnell PJ; Eberhart C; Pitha I; Zack DJ; Campochiaro PA; Hanes J; Ensign LM
Nat Biomed Eng; 2020 Nov; 4(11):1053-1062. PubMed ID: 32895514
[TBL] [Abstract][Full Text] [Related]
16. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
[TBL] [Abstract][Full Text] [Related]
17. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
18. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.
Daull P; Lallemand F; Garrigue JS
J Pharm Pharmacol; 2014 Apr; 66(4):531-41. PubMed ID: 24001405
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic drug delivery systems--recent advances.
Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
[TBL] [Abstract][Full Text] [Related]
20. [Ways to improve ocular bioavailability for topical applications].
Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
